75 filings
8-K
AMRX
Amneal Pharmaceuticals Inc - Ordinary Shares
7 May 24
Submission of Matters to a Vote of Security Holders
4:18pm
8-K
AMRX
Amneal Pharmaceuticals Inc - Ordinary Shares
3 May 24
Amneal Reports First Quarter 2024 Financial Results
6:14am
8-K
AMRX
Amneal Pharmaceuticals Inc - Ordinary Shares
1 Mar 24
Amneal Reports Fourth Quarter and Full Year 2023 Financial Results
6:13am
8-K
AMRX
Amneal Pharmaceuticals Inc - Ordinary Shares
10 Jan 24
Results of Operations and Financial Condition
7:03am
8-K
AMRX
Amneal Pharmaceuticals Inc - Ordinary Shares
15 Dec 23
Amneal Announces Move to Nasdaq
4:15pm
8-K/A
f82vgo79g 8awk
15 Dec 23
Financial Statements and Exhibits
4:06pm
8-K
90zu42kh5am12vkqvr2
14 Nov 23
Entry into a Material Definitive Agreement
5:04pm
8-K
4rqvhpwkw8ng0x3hl2
7 Nov 23
Amneal Reports Third Quarter 2023 Financial Results
6:21am
8-K
qg8i9b2vxt5v67p u1fs
23 Oct 23
Amneal Reports Certain Preliminary Third Quarter 2023 Financial Results
4:16pm
8-K
rx6i6xv0 sp
17 Oct 23
Entry into a Material Definitive Agreement
6:51am
8-K
3v6rtk
4 Aug 23
Amneal Reports Second Quarter 2023 Financial Results
6:22am
8-K
qben0ykc fcdxu69d9
19 May 23
In the Court of Chancery of the State of Delaware
4:06pm
8-K
qfqxng uzqdu
12 May 23
Submission of Matters to a Vote of Security Holders
4:29pm
8-K
my6j85u
5 May 23
Amneal Reports First Quarter 2023 Financial Results
6:17am
8-K
jhevzez9rmhhgrd4zl
17 Apr 23
Amneal Reports Certain Preliminary First Quarter 2023 Financial Results
6:43am
8-K
p5ml29t6813b3lg
2 Mar 23
Amneal Reports Fourth Quarter and Full Year 2022 Financial Results
6:27am
8-K
sdxnm4d64k9fager5o8
10 Jan 23
Results of Operations and Financial Condition
6:05am
8-K
2zw6smsjvj2g15m5
4 Nov 22
Amneal Reports Third Quarter 2022 Financial Results
6:24am
8-K
s29y9
6 Sep 22
Amneal Appoints Gustavo Pesquin as Executive Vice President, Chief Commercial Officer – Specialty
4:15pm
8-K
blc21dt kxw5orjjk3mt
5 Aug 22
Amneal Reports Second Quarter 2022 Financial Results
6:11am